Discovery of Furanone-Based Radiopharmaceuticals for Diagnostic Targeting of COX-1 in Ovarian Cancer-Reference-Cited by-同舟云学术

Discovery of Furanone-Based Radiopharmaceuticals for Diagnostic Targeting of COX-1 in Ovarian Cancer

Published:2019-05-24 Issue:5 Volume:4 Page:9251-9261
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Uddin Md. Jashim^ORCID,Wilson Andrew J.,Crews Brenda C.,Malerba Paola¹,Uddin Md. Imam^ORCID,Kingsley Philip J.,Ghebreselasie Kebreab,Daniel Cristina K.,Nickels Michael L.,Tantawy Mohammed N.,Jashim Elma²,Manning H. Charles^ORCID,Khabele Dineo³,Marnett Lawrence J.^ORCID

Affiliation:

1. Department of Pharmacy & Pharmaceutical Sciences, University of Bari “A. Moro”, Via Orabona 4, 70125 Bari, Italy

2. Martin Luther King Jr. Academic Magnet School of Health Sciences and Engineering, 613 17th Avenue North, Nashville, Tennessee 37203, United States

3. Department of Obstetrics and Gynecology, University of Kansas School of Medicine, Kansas City, Kansas 66160, United States

Funder

National Cancer Institute

V Foundation for Cancer Research

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link